Apolipoproteins and coronary artery disease

B. A. Kottke, A. R. Zinsmeister, David Holmes, R. W. Kneller, B. J. Hallaway, S. J. Mao

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

In this study, we compared the relative utility of plasma levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and apolipoproteins in identifying men with angiographically significant coronary artery disease in a combined sample of consecutive male patients undergoing coronary angiography (N = 304) and healthy, normal male control subjects (N = 135). The plasma apolipoprotein levels were measured by using specific radioimmunoassays. We found that plasma levels of apolipoprotein A-I, followed by those of apolipoprotein A-II and B, were better discriminators than plasma cholesterol, triglycerides, or HDL cholesterol levels for identifying those with coronary artery disease. In confirmation of previous findings, the presence of coronary artery disease resulted in lower levels of apolipoproteins A-I and A-II and HDL-cholesterol and higher levels of apolipoprotein B, cholesterol and triglycerides. Linear and quadratic discriminant function analysis demonstrated that by using the age of the patients and apolipoprotein A-I, A-II and B levels, one could correctly classify patients either as being normal or as having angiographically significant coronary artery disease in more than 75% of the cases. Thus, plasma apolipoprotein levels (especially A-I and A-II) may be considerably better markers for coronary artery disease than traditional lipid determinations.

Original languageEnglish (US)
Pages (from-to)313-320
Number of pages8
JournalMayo Clinic Proceedings
Volume61
Issue number5
StatePublished - 1986

Fingerprint

Apolipoproteins
Coronary Artery Disease
Apolipoprotein A-I
HDL Cholesterol
Triglycerides
Cholesterol
Apolipoproteins B
Apolipoprotein A-II
Discriminant Analysis
Coronary Angiography
Radioimmunoassay
Lipids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kottke, B. A., Zinsmeister, A. R., Holmes, D., Kneller, R. W., Hallaway, B. J., & Mao, S. J. (1986). Apolipoproteins and coronary artery disease. Mayo Clinic Proceedings, 61(5), 313-320.

Apolipoproteins and coronary artery disease. / Kottke, B. A.; Zinsmeister, A. R.; Holmes, David; Kneller, R. W.; Hallaway, B. J.; Mao, S. J.

In: Mayo Clinic Proceedings, Vol. 61, No. 5, 1986, p. 313-320.

Research output: Contribution to journalArticle

Kottke, BA, Zinsmeister, AR, Holmes, D, Kneller, RW, Hallaway, BJ & Mao, SJ 1986, 'Apolipoproteins and coronary artery disease', Mayo Clinic Proceedings, vol. 61, no. 5, pp. 313-320.
Kottke BA, Zinsmeister AR, Holmes D, Kneller RW, Hallaway BJ, Mao SJ. Apolipoproteins and coronary artery disease. Mayo Clinic Proceedings. 1986;61(5):313-320.
Kottke, B. A. ; Zinsmeister, A. R. ; Holmes, David ; Kneller, R. W. ; Hallaway, B. J. ; Mao, S. J. / Apolipoproteins and coronary artery disease. In: Mayo Clinic Proceedings. 1986 ; Vol. 61, No. 5. pp. 313-320.
@article{ec15f64f9d6745df9a3cc665a0f24268,
title = "Apolipoproteins and coronary artery disease",
abstract = "In this study, we compared the relative utility of plasma levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and apolipoproteins in identifying men with angiographically significant coronary artery disease in a combined sample of consecutive male patients undergoing coronary angiography (N = 304) and healthy, normal male control subjects (N = 135). The plasma apolipoprotein levels were measured by using specific radioimmunoassays. We found that plasma levels of apolipoprotein A-I, followed by those of apolipoprotein A-II and B, were better discriminators than plasma cholesterol, triglycerides, or HDL cholesterol levels for identifying those with coronary artery disease. In confirmation of previous findings, the presence of coronary artery disease resulted in lower levels of apolipoproteins A-I and A-II and HDL-cholesterol and higher levels of apolipoprotein B, cholesterol and triglycerides. Linear and quadratic discriminant function analysis demonstrated that by using the age of the patients and apolipoprotein A-I, A-II and B levels, one could correctly classify patients either as being normal or as having angiographically significant coronary artery disease in more than 75{\%} of the cases. Thus, plasma apolipoprotein levels (especially A-I and A-II) may be considerably better markers for coronary artery disease than traditional lipid determinations.",
author = "Kottke, {B. A.} and Zinsmeister, {A. R.} and David Holmes and Kneller, {R. W.} and Hallaway, {B. J.} and Mao, {S. J.}",
year = "1986",
language = "English (US)",
volume = "61",
pages = "313--320",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Apolipoproteins and coronary artery disease

AU - Kottke, B. A.

AU - Zinsmeister, A. R.

AU - Holmes, David

AU - Kneller, R. W.

AU - Hallaway, B. J.

AU - Mao, S. J.

PY - 1986

Y1 - 1986

N2 - In this study, we compared the relative utility of plasma levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and apolipoproteins in identifying men with angiographically significant coronary artery disease in a combined sample of consecutive male patients undergoing coronary angiography (N = 304) and healthy, normal male control subjects (N = 135). The plasma apolipoprotein levels were measured by using specific radioimmunoassays. We found that plasma levels of apolipoprotein A-I, followed by those of apolipoprotein A-II and B, were better discriminators than plasma cholesterol, triglycerides, or HDL cholesterol levels for identifying those with coronary artery disease. In confirmation of previous findings, the presence of coronary artery disease resulted in lower levels of apolipoproteins A-I and A-II and HDL-cholesterol and higher levels of apolipoprotein B, cholesterol and triglycerides. Linear and quadratic discriminant function analysis demonstrated that by using the age of the patients and apolipoprotein A-I, A-II and B levels, one could correctly classify patients either as being normal or as having angiographically significant coronary artery disease in more than 75% of the cases. Thus, plasma apolipoprotein levels (especially A-I and A-II) may be considerably better markers for coronary artery disease than traditional lipid determinations.

AB - In this study, we compared the relative utility of plasma levels of cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and apolipoproteins in identifying men with angiographically significant coronary artery disease in a combined sample of consecutive male patients undergoing coronary angiography (N = 304) and healthy, normal male control subjects (N = 135). The plasma apolipoprotein levels were measured by using specific radioimmunoassays. We found that plasma levels of apolipoprotein A-I, followed by those of apolipoprotein A-II and B, were better discriminators than plasma cholesterol, triglycerides, or HDL cholesterol levels for identifying those with coronary artery disease. In confirmation of previous findings, the presence of coronary artery disease resulted in lower levels of apolipoproteins A-I and A-II and HDL-cholesterol and higher levels of apolipoprotein B, cholesterol and triglycerides. Linear and quadratic discriminant function analysis demonstrated that by using the age of the patients and apolipoprotein A-I, A-II and B levels, one could correctly classify patients either as being normal or as having angiographically significant coronary artery disease in more than 75% of the cases. Thus, plasma apolipoprotein levels (especially A-I and A-II) may be considerably better markers for coronary artery disease than traditional lipid determinations.

UR - http://www.scopus.com/inward/record.url?scp=0022477498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022477498&partnerID=8YFLogxK

M3 - Article

C2 - 3702492

AN - SCOPUS:0022477498

VL - 61

SP - 313

EP - 320

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -